IT1209229B - Uso di composti perfluorocarburici per il trattamento di lesioni,articoli e composizioni contenenti detti composti - Google Patents

Uso di composti perfluorocarburici per il trattamento di lesioni,articoli e composizioni contenenti detti composti

Info

Publication number
IT1209229B
IT1209229B IT8022637A IT2263780A IT1209229B IT 1209229 B IT1209229 B IT 1209229B IT 8022637 A IT8022637 A IT 8022637A IT 2263780 A IT2263780 A IT 2263780A IT 1209229 B IT1209229 B IT 1209229B
Authority
IT
Italy
Prior art keywords
compounds
injuries
articles
treatment
compositions containing
Prior art date
Application number
IT8022637A
Other languages
English (en)
Other versions
IT8022637A0 (it
Inventor
White David Charles
Original Assignee
Suntech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntech filed Critical Suntech
Publication of IT8022637A0 publication Critical patent/IT8022637A0/it
Application granted granted Critical
Publication of IT1209229B publication Critical patent/IT1209229B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/202—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with halogen atoms, e.g. triclosan, povidone-iodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/13—Burn treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Materials For Medical Uses (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IT8022637A 1979-06-25 1980-06-06 Uso di composti perfluorocarburici per il trattamento di lesioni,articoli e composizioni contenenti detti composti IT1209229B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5204179A 1979-06-25 1979-06-25

Publications (2)

Publication Number Publication Date
IT8022637A0 IT8022637A0 (it) 1980-06-06
IT1209229B true IT1209229B (it) 1989-07-16

Family

ID=21975053

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8022637A IT1209229B (it) 1979-06-25 1980-06-06 Uso di composti perfluorocarburici per il trattamento di lesioni,articoli e composizioni contenenti detti composti

Country Status (8)

Country Link
US (1) US4366169A (it)
EP (1) EP0031353B1 (it)
BE (1) BE883998A (it)
CA (1) CA1161760A (it)
DE (1) DE3049665T1 (it)
GB (1) GB2070429B (it)
IT (1) IT1209229B (it)
WO (1) WO1981000002A1 (it)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4569784A (en) * 1980-11-17 1986-02-11 Adamantech, Inc. Preparation of a gel having gas transporting capability
US5214214A (en) * 1981-09-08 1993-05-25 The Green Cross Corporation Perfluoro branched alkyl ethers and emulsions
US4879062A (en) * 1981-10-20 1989-11-07 Adamantech, Inc. Preparation of a gel having gas transporting capability
US4490351A (en) * 1982-03-15 1984-12-25 Children's Hospital Medical Center Methods of treating disorders of an eye with liquid perfluorocarbons
US4452818A (en) * 1982-03-19 1984-06-05 Haidt Sterling J Extraocular method of treating the eye with liquid perfluorocarbons
US4742050B1 (en) * 1982-08-17 1994-06-28 Alpha Therapeutic Corp Sensitization of hypoxic tumor cells and control of growth thereof
US4889525A (en) * 1982-08-17 1989-12-26 Adamantech, Inc. Sensitization of hypoxic tumor cells and control of growth thereof
WO1984000686A1 (en) * 1982-08-17 1984-03-01 Sun Tech Inc Perfluorocarbon emulsions and their preparation and use in therapy
JPS59139252A (ja) * 1982-11-26 1984-08-10 チルドレンズ・ホスピタル・メデイカル・センタ− 眼の眼外処置用装置
JPS59130812A (ja) * 1983-01-14 1984-07-27 Green Cross Corp:The 癌化学療法補助剤
JPS59130813A (ja) * 1983-01-14 1984-07-27 Green Cross Corp:The 癌化学療法補助剤
US4520109A (en) * 1983-03-14 1985-05-28 Sun Tech, Inc. Fluorocarbon tracers and tracing method
US4865836A (en) * 1986-01-14 1989-09-12 Fluoromed Pharmaceutical, Inc. Brominated perfluorocarbon emulsions for internal animal use for contrast enhancement and oxygen transport
US5514720A (en) * 1986-07-09 1996-05-07 Hemagen/Pfc Stable emulsions of highly fluorinated organic compounds
US5684050A (en) * 1986-01-24 1997-11-04 Hemagen/Pfc Stable emulsions of highly fluorinated organic compounds
JPH01503146A (ja) * 1986-09-19 1989-10-26 ケメックス　ファーマシューティカルズ，インコーポレイティド 身体組織の治療方法および身体組織への医薬の投与方法
IL84911A (en) * 1987-12-22 1993-04-04 Yissum Res Dev Co Processes for the preparation of collagen products, and pharmaceutical compositions containing the same
US5171755A (en) * 1988-04-29 1992-12-15 Hemagen/Pfc Emulsions of highly fluorinated organic compounds
US6458376B1 (en) 1990-09-27 2002-10-01 Allergan, Inc. Nonaqueous fluorinated drug delivery suspensions
US5518731A (en) * 1990-09-27 1996-05-21 Allergan, Inc. Nonaqueous fluorinated drug delivery vehicle suspensions
US5173298A (en) * 1990-09-27 1992-12-22 Allergan, Inc. Nonaqueous fluorinated drug delivery vehicle suspensions
SE467384B (sv) * 1990-10-24 1992-07-06 Ericsson Telefon Ab L M Saett och kopplingsanordning foer att vid omriktare balansera ingaangs- och/eller utgaangsspaenningsavvikelser
DE4100059C2 (de) * 1991-01-03 1994-08-25 Adatomed Pharma & Med Behandlungsflüssigkeit zum Wiederanlegen (Entfalten) abgelöster Netzhaut an die Aderhaut des Auges
US5200430A (en) * 1991-03-21 1993-04-06 Escalon Ophthalmics, Inc. Debridement of bodily cavities using debridement fluids
US5403575A (en) * 1991-12-12 1995-04-04 Hemagen/Pfc Highly fluorinated, chloro-substituted organic compound-containing emulsions and methods of using them
DE4221268C2 (de) * 1992-06-26 1997-06-12 Lancaster Group Ag Verwendung eines Dermatikums zur Unterstützung des Sauerstofftransportes in der Haut
US5350359A (en) * 1992-07-16 1994-09-27 Temple University Of The Commonwealth System Of Higher Education Control, treatment and/or diagnosis of physiological conditions with degassed perfluorocarbon liquid
US5336175A (en) * 1992-10-29 1994-08-09 Mames Robert N Method for the treatment of retinal detachments
FR2710840B1 (fr) * 1993-10-04 1995-12-01 Applic Transferts Technolo Compositions viscoélastiques hautement concentrées en composés fluorés, leur préparation et leurs utilisations dans le domaine médical et en cosmétique.
US5480914A (en) * 1994-05-06 1996-01-02 Allergan, Inc. Nonaqueous thixotropic drug delivery suspensions and methods of their use
RU2088223C1 (ru) * 1994-06-29 1997-08-27 Игорь Вячеславович Белов Антиметастатическое средство
US5865784A (en) 1995-06-07 1999-02-02 Alliance Pharmaceutical Corp. Method of hemodilution facilitated by monitoring oxygenation status
US5834519A (en) * 1996-10-11 1998-11-10 Wayne State University Stabilized gas-supersaturated emulsions and suspensions
US6113932A (en) * 1998-03-02 2000-09-05 Children's Hospital Medical Center Nontoxic vernix compositions and method of producing
US6562358B2 (en) 1998-03-02 2003-05-13 Children's Hospital Medical Center Nontoxic vernix compositions and method of producing
US6333041B1 (en) 1998-03-02 2001-12-25 Children's Hospital Medical Center Nontoxic vernix compositions and method of producing
US7008535B1 (en) 2000-08-04 2006-03-07 Wayne State University Apparatus for oxygenating wastewater
US6649145B2 (en) * 2001-02-01 2003-11-18 Hydron Technologies, Inc. Compositions and method of tissue superoxygenation
US7288574B2 (en) * 2001-07-18 2007-10-30 Eckert C Edward Two-phase oxygenated solution and method of use
US8142412B2 (en) * 2002-01-03 2012-03-27 Oxira Medical Inc. Method and apparatus for delivering oxygen and/or other gases to tissue
US7481799B2 (en) * 2002-01-03 2009-01-27 Oxira Medical Inc. Delivery source of oxygen
WO2003086254A1 (en) * 2002-04-05 2003-10-23 Balding David P Oxygen enriched implant for orthopedic wounds
US6911457B2 (en) 2002-04-11 2005-06-28 Carbomer, Inc. Diabetes imaging probes
AU2003234709A1 (en) * 2002-04-11 2003-10-27 Carbomer Fluorinated or paramagnetic alginate polymer, annexin paramagnetic conjugate, and their use as contrasting agent in mri
US7959935B2 (en) * 2002-05-03 2011-06-14 Children's Hospital Medical Center Simulated vernix compositions for skin cleansing and other applications
US7357937B2 (en) * 2002-09-24 2008-04-15 Therox, Inc. Perfluorocarbon emulsions with non-fluorinated surfactants
GB0224986D0 (en) * 2002-10-28 2002-12-04 Smith & Nephew Apparatus
US7198179B2 (en) * 2003-02-25 2007-04-03 Therox, Inc. System for storing and dispensing a gas-solubilized product
DE10336841A1 (de) * 2003-08-11 2005-03-17 Rovi Gmbh & Co. Kosmetische Rohstoffe Kg Kosmetische Zusammensetzung zur Unterstützung des Sauerstofftransports in die Haut
US7785584B2 (en) * 2003-08-13 2010-08-31 Healthpoint, Ltd. Ointment wound spray
US11298453B2 (en) 2003-10-28 2022-04-12 Smith & Nephew Plc Apparatus and method for wound cleansing with actives
US7753894B2 (en) 2004-04-27 2010-07-13 Smith & Nephew Plc Wound cleansing apparatus with stress
US10413644B2 (en) 2004-04-27 2019-09-17 Smith & Nephew Plc Wound treatment apparatus and method
GB0409446D0 (en) 2004-04-28 2004-06-02 Smith & Nephew Apparatus
US8529548B2 (en) 2004-04-27 2013-09-10 Smith & Nephew Plc Wound treatment apparatus and method
US20060258995A1 (en) * 2004-10-20 2006-11-16 Pendharkar Sanyog M Method for making a reinforced absorbable multilayered fabric for use in medical devices
US9358318B2 (en) * 2004-10-20 2016-06-07 Ethicon, Inc. Method of making a reinforced absorbable multilayered hemostatic wound dressing
DK1809343T3 (da) * 2004-10-20 2012-11-26 Ethicon Inc Forstærket absorberbar hæmostatisk flerlagssårforbinding samt fremstillingsfremgangsmåde
MX2008002882A (es) 2005-09-07 2008-03-27 Tyco Healthcare Aposito de herida con deposito de vacio.
US9017717B2 (en) * 2006-01-16 2015-04-28 Peach Technologies Llc Bandage for facilitating transdermal respiration and healing
US8535691B2 (en) * 2006-02-16 2013-09-17 Peach Technologies, LLC. Perflurochemical treatment process and apparatus
AU2007249200B2 (en) * 2006-05-15 2013-12-19 Virginia Commonwealth University Methods and compositions for controlled and sustained production and delivery of peroxides
EP2035082A4 (en) * 2006-06-07 2012-02-08 Trinity Wound Inst Llc OXYGEN THERAPY WITH ULTRASOUND
US20090202617A1 (en) * 2008-02-13 2009-08-13 Ward Kevin R Gas based wound and tissue therapeutics
WO2010033187A1 (en) * 2008-09-19 2010-03-25 Oxygen Biotherapeutics, Inc. Deep immersion flotation therapy for burn victims
US8343515B2 (en) * 2008-11-25 2013-01-01 Oxygen Biotherapeutics, Inc. Perfluorocarbon gel formulations
US20100144597A1 (en) * 2008-12-10 2010-06-10 Ward Kevin R Novel combinatorial approaches to enhancing oxygen transport to tissues
DE102009026718A1 (de) 2009-06-04 2010-04-15 Henkel Ag & Co. Kgaa Hautbehandlung zur Porenverfeinerung II
WO2011116277A1 (en) * 2010-03-19 2011-09-22 Oxygen Biotherapeutics, Inc. Perfluorocarbon eye cream formulations
RU2446833C2 (ru) * 2010-06-22 2012-04-10 Муниципальное учреждение здравоохранения. Городская Клиническая больница № 11 Способ кожной пластики
EP2587917A4 (en) * 2010-07-01 2015-05-06 Mtm Res Llc THERAPIES USING ANTIFIBROBLASTIC FLUOROCHEMICAL EMULSIONS
US8513309B2 (en) 2010-10-01 2013-08-20 Oxygen Biotherapeutics, Inc. Perfluorocarbons for use in treating pruritus
US20130079800A1 (en) * 2011-08-04 2013-03-28 C. Edward Eckert Method for debriding human tissue
TR201808493T4 (tr) * 2011-08-26 2018-07-23 On Light Sciences Inc Dövme silme sistemi ve yöntemi.
WO2013063354A1 (en) * 2011-10-27 2013-05-02 Novan, Inc. Nitric oxide releasing bath compositions and methods of using the same
US20140213548A1 (en) * 2013-01-27 2014-07-31 New Jersey Institute Of Technology System and method for hemostatic wound dressing
JP2018525489A (ja) 2015-08-11 2018-09-06 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ 材料複合体
CN112999410B (zh) * 2021-03-05 2022-11-15 江苏君隽生物科技有限公司 含全氟萘烷的纳米氧合水凝胶促愈合敷料及其制法和用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2968628A (en) * 1958-10-17 1961-01-17 Shulton Inc Propellant composition
US3911138B1 (en) * 1973-02-26 1996-10-29 Childrens Hosp Medical Center Artificial blood and method for supporting oxygen transport in animals
JPS5331209B2 (it) * 1973-10-05 1978-09-01
US3993581A (en) * 1973-10-05 1976-11-23 The Green Cross Corporation Process for preparing stable oxygen transferable emulsion
FR2280360A1 (fr) * 1974-08-02 1976-02-27 Sogeras Composition cosmetologique oxygenante
US4105798A (en) * 1976-07-19 1978-08-08 Sun Ventures, Inc. Perfluoro polycyclic compounds for use as synthetic blood and perfusion media
US4216233A (en) * 1978-12-06 1980-08-05 Stein Karl N Method for treatment of skin burns in mammals
BE881267A (fr) * 1980-01-18 1980-05-16 Stein Karl N Methode pour le traitement de brulures de la peau chez les mammiferes

Also Published As

Publication number Publication date
DE3049665C2 (it) 1988-11-24
GB2070429A (en) 1981-09-09
DE3049665T1 (de) 1982-03-18
EP0031353B1 (en) 1984-08-08
US4366169A (en) 1982-12-28
EP0031353A4 (fr) 1982-07-06
GB2070429B (en) 1984-05-02
EP0031353A1 (en) 1981-07-08
WO1981000002A1 (en) 1981-01-08
CA1161760A (en) 1984-02-07
BE883998A (fr) 1980-12-29
IT8022637A0 (it) 1980-06-06

Similar Documents

Publication Publication Date Title
IT1209229B (it) Uso di composti perfluorocarburici per il trattamento di lesioni,articoli e composizioni contenenti detti composti
IT1181593B (it) Composizione per il trattamento di tappeti
GB2041389B (en) Processes for the preparation of organopoly-siloxanes suitable for use as active compounds for non-stick coating compositions
PH16326A (en) New chemical compounds,pharmaceutical compositions containing the same and method of use
IT1151031B (it) Composizione per pulitura,in particolare per l'eliminazione di fondente per saldatura
IT8024369A0 (it) Preparazione contenente metilsolfonilmetano e procedimenti per l'impiego e la purificazione di essa.
DE3782182T2 (de) Azacycloalkanderivate, absorptionspromotoren, die die derivate als effektiven inhaltsstoff enthalten und aeusserlich anzuwendende praeparate, die absorptionspromotoren enthalten.
DE3064984D1 (en) Use of 2-chloro-4,6-diamino-s-triazines as algicides
NZ192195A (en) 1-triazolyl-2-hydroxy-2-phenyl-3-aryl-propanes and pharmaceutical compositions
IT7925699A0 (it) Composizioni fotografiche di sbianca, e metodi per trattamento fotografico.
IT1121808B (it) Procedimento per la preparazione di 1,4-butindiolo e relativo catalizzatore
SE7714558L (sv) Forening med desinficerande, aktivitet och farmaceutiska kompositioner innehallande denna
DE3063905D1 (en) Compounds having antitumour properties, process for their preparation, these compounds for use as antitumour agents and pharmaceutical compositions containing them
IT1155615B (it) Composizione gelificata per bastoncini ad uso cosmetico
IT8048909A0 (it) Procedimento per la preparazione di solfenammidi
IT7925706A0 (it) Uso di glicerilfosforilderivati nella terapia di dislipemie ed epatiti, e composizioni farmaceutiche relative.
IT8919172A0 (it) Composizioni contenenti bismuto idonee per uso terapeutico.
IT8047889A0 (it) Procedimento per la fabbricazione di contenitori aperti in particolare per uso sanitario
NO913774D0 (no) Cykloheksylfenylpyrimidiner, fremgangsmaate for fremstilling og anvendelse i flytende krystallinske blandinger.
ZA793077B (en) Derivatives of 1,3,5-triazacycloheptane-2,4-dione,the process for their preparation and their use as polymer stabilisers
IT1061335B (it) Procedimento per trattare ti.cl.3 impiegabile nella polimerizzazione di olefine
IT8022667A0 (it) Didodecilammonio beta-ottamolibdato e composizione contenente lo stesso.
IT1143191B (it) Composto di biureto 1,1,3,5-sostituito procedimento per prepararlo e composizione farmaceutica che lo contiene
IT7927490A0 (it) Composti di azepino [1,2,3-lm]beta-carbolina e relativo procedimento per prepararli
IT8319024A0 (it) Composizione medicinale per il trattamento di certe neurovirosi.

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19940625